Results 61 to 70 of about 1,267,687 (231)

Frequency of anti‐neural antibodies and autoimmune epilepsy in focal epilepsy of unknown etiology: An observational study in a Singaporean cohort

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Autoimmune epilepsy (AES) is increasingly recognized as a condition in patients with epilepsy of unknown etiology. Early immunotherapy improves outcomes; however, data on its prevalence and the frequency of anti‐neural/neuronal antibodies in Asian populations remain scarce.
Seong Jin Park   +14 more
wiley   +1 more source

Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial [PDF]

open access: yes, 2013
Background: Dystonic cerebral palsy is primarily caused by damage to the basal ganglia and central cortex. The daily care of these patients can be difficult due to dystonic movements.
Strijers, Rob L. M.   +38 more
core   +1 more source

Dystonic tremor and blepharospasm in a patient with deletion of 18q

open access: yes, 2023
18q- Syndrome is a rare chromosomic syndrome where neurological involvement is scarcely described. Movement disorders are rare and only one case with dystonia was described.
Valente M.   +6 more
core   +1 more source

“It Was Something Outside of Me, Controlling Me”: Young People's Perspectives on the Role of Externalisation in Recovery From Anorexia Nervosa

open access: yesJournal of Clinical Psychology, EarlyView.
ABSTRACT Objective Externalisation is a therapeutic approach that separates the problem from the person, widely used in treating anorexia nervosa (AN) to help young people understand their illness and to collaborate with their families against the disorder.
Alex Skolnick   +2 more
wiley   +1 more source

Pitch Strength & Percent Vocal Creak to Assess Treatment Response in Adductor Laryngeal Dystonia

open access: yesThe Laryngoscope, EarlyView.
Pitch Strength (PS) and Percent Vocal Creak (%VC) were measured before and after botulinum neurotoxin treatment in patients with adductor laryngeal dystonia (AdLD). While PS and %VC correlated with changes in disruption frequency and perceptual severity, they did not demonstrate robust group‐level treatment sensitivity.
Jesse D. Hoffmeister   +5 more
wiley   +1 more source

"Club-Cutting" Dystonic Tremor: a Case Report [PDF]

open access: yes, 2013
Background: Focal task-specific dystonic postures are well recognized. Often a tremor may be the main feature with little or no dystonia. These have been well reported in writers, musicians, and sportspeople.Case Report: Herein we report a ...
Timothy Lynch   +7 more
core   +1 more source

Acute dystonia in a patient with 22q11.2 deletion syndrome

open access: yesMental Illness, 2015
The 22q11.2 deletion syndrome (di George syndrome) is one of the most prevalent genetic disorders. The clinical features of the syndrome are distinct facial appearance, velopharyngeal insufficiency, conotruncal heart disease, parathyroid and immune ...
Konstantinos Kontoangelos   +4 more
doaj   +1 more source

Orofacial Drinking Tremor: A Case Series and Literature Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Task‐specific orofacial tremor is a rare condition in which rhythmic oscillations of orofacial muscles occur during specific actions. Drinking tremor represents a recurrent pattern in isolated reports, although its phenomenology and underlying mechanisms remain incompletely defined.
Daniele Birreci   +7 more
wiley   +1 more source

Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA

open access: yesToxins
The therapeutic efficacy remaining from prior treatments with botulinum toxins (BoNTs) when cervical dystonia (CD) patients prefer to be re-treated has not been well characterized. Here, we assessed the residual therapeutic efficacy of BoNT injections at
Aaron Ellenbogen   +7 more
doaj   +1 more source

Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information

open access: yesToxins
The first-line management of cervical dystonia (CD) symptoms is intramuscular injection of botulinum toxin type A (BoNTA). However, a comparison of safety among BoNTAs is difficult because, per regulatory authorities, units of BoNTA activity are not ...
Khashayar Dashtipour   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy